Rutherrin(R), when combined with a common diabetic drug and radiation, was able to effectively destroy Non-Hodgkin's Lymphoma ...

(NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the resubmission of the Biologics License Application (BLA) for odronextamab in ...

Studies reveal that over 50% of food samples in India have pesticide residues beyond safe limits, linking them to increased ...

Irene Felux Brewer, born on May 30, 1953, in Floresville, Texas, passed away peacefully at South Arkansas Regional Hospital on Wednesday, Feb. 19, 2025, after a long battle with Non- Hodgkin’s ...

Melissa Coulier, co-founder of Live Well Lead Well, uses holistic wellness to aid Dave's cancer journey and help others ...

A YOUNG Ryedale woman who has battled cancer three times over the last decade is hosting a a charity ball to raise funds for organisations that ...

Stem cell research and regenerative medicine are growing markets in the life science sector, and the top stem cell companies ...

Since his wife died, David Morris has devoted his life to driving cancer patients to hospitals around the region. Now, the charity he supports ...

StockNews.com initiated coverage on shares of Eagle Pharmaceuticals (NASDAQ:EGRX – Free Report) in a research report released on Tuesday morning. The firm issued a hold rating on the specialty ...

Saint John's High School junior Lily Dunlap told ABC13 that her faith in God, her family, and basketball got her through her battle with cancer, leading her to win Naismith Courage Award.

Sanofi's Sarclisa (isatuximab) has gained approval from Japan’s MHLW for use in conjunction with VRd to treat newly diagnosed ...

LUND, SE / ACCESS Newswire / February 25, 2025 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV) invites investors, analysts, and the press to a presentation of the Year-end report 20 ...